CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Intra-cellular Therapies, Inc.  (ITCI)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Intra-cellular Therapies's Quick Ratio

ITCI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

ITCI Quick Ratio (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Current Liabilities Change -64.07 % 82.4 % 68.15 % 1254.48 % 107.99 %
Y / Y Cash & cash equivalent Change -22.6 % -19.36 % -19.17 % 5.3 % 117.02 %
Quick Ratio MRQ 49.21 22.54 36.47 3.82 22.84
Overall Ranking # 45 # 128 # 125 # 128 #
Seq. Current Liabilities Change -57.33 % 54.94 % -92.51 % 625.91 % 116.63 %
Seq. Cash & cash equivalent Change -6.84 % -4.25 % -28.58 % 21.48 % -2.93 %



Quick Ratio second quarter 2017 Comment
Current Liabilities decreased faster than Intra-cellular Therapies's Cash & cash equivalent, this led to improvement in Intra-cellular Therapies's Quick Ratio to 49.21, Quick Ratio remained below Intra-cellular Therapies, Inc. average.

Within Major Pharmaceutical Preparations industry only one company achieved higher Quick Ratio in second quarter 2017. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are ITCI Segments?
See Quick Ratio ITCI on the trailing twelve month basis
Quick Ratio second quarter 2017 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 2
Healthcare Sector # 6
Overall Market # 45


Quick Ratio Statistics
High Average Low
75.87 27.73 0
(Dec 31 2015)   (Jun 30 2013)


You need to upgrade your Flash Player


Financial Statements
Intra-cellular Therapies's Current Liabilities $ 7 Millions Visit ITCI's Balance sheet
Intra-cellular Therapies's Cash & cash equivalent $ 343 Millions Visit ITCI's Balance sheet
Source of ITCI's Sales Visit ITCI's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2017, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2017 MRQ Cash & cash equivalentJun 30 2017 MRQ Current Liabilities
Syros Pharmaceuticals, Inc.  61.92 $ 91.521  Millions$ 1.478  Millions
Intra-cellular Therapies, Inc.  49.21 $ 342.628  Millions$ 6.963  Millions
Loxo Oncology, Inc.  41.81 $ 467.585  Millions$ 11.183  Millions
Kindred Biosciences, Inc.  29.17 $ 73.545  Millions$ 2.521  Millions
Inotek Pharmaceuticals Corporation  27.08 $ 108.754  Millions$ 4.016  Millions
Corvus Pharmaceuticals, Inc.  26.66 $ 110.326  Millions$ 4.138  Millions
Prothena Corp Plc  25.09 $ 471.729  Millions$ 18.800  Millions
Achillion Pharmaceuticals Inc  25.00 $ 350.455  Millions$ 14.020  Millions
Flex Pharma, Inc.  24.76 $ 47.123  Millions$ 1.903  Millions
Dermira, Inc.  24.15 $ 690.761  Millions$ 28.603  Millions
Endocyte Inc  22.60 $ 118.395  Millions$ 5.239  Millions
Glycomimetics Inc  21.88 $ 119.200  Millions$ 5.447  Millions
Sierra Oncology, Inc.  21.13 $ 116.699  Millions$ 5.523  Millions
Chimerix Inc  19.12 $ 148.528  Millions$ 7.768  Millions
Catalyst Pharmaceuticals, Inc.  19.09 $ 35.131  Millions$ 1.840  Millions
Tonix Pharmaceuticals Holding Corp.  18.78 $ 34.366  Millions$ 1.830  Millions
Paratek Pharmaceuticals, Inc.  18.75 $ 175.453  Millions$ 9.357  Millions
Flexion Therapeutics Inc  18.17 $ 359.859  Millions$ 19.805  Millions
Enanta Pharmaceuticals Inc  17.26 $ 192.015  Millions$ 11.122  Millions
Concert Pharmaceuticals, Inc.  17.02 $ 103.420  Millions$ 6.077  Millions
Aquinox Pharmaceuticals, Inc  16.15 $ 131.277  Millions$ 8.128  Millions
Dynavax Technologies Corp  16.14 $ 126.961  Millions$ 7.865  Millions
Medicinova Inc  16.12 $ 22.890  Millions$ 1.420  Millions
Spring Bank Pharmaceuticals, Inc.  15.91 $ 56.379  Millions$ 3.544  Millions
Otonomy, Inc.  15.83 $ 150.532  Millions$ 9.510  Millions
Aduro Biotech, Inc.  15.19 $ 377.243  Millions$ 24.831  Millions
Ovid Therapeutics Inc.  15.08 $ 106.546  Millions$ 7.065  Millions
Beigene, Ltd.  14.80 $ 407.430  Millions$ 27.525  Millions
Sophiris Bio Inc.  14.48 $ 24.029  Millions$ 1.660  Millions
Aeglea Biotherapeutics, Inc.  14.35 $ 63.393  Millions$ 4.418  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
LSYN's Profile
Stock Price
LSYN's Financials
LSYN's Expectations
Business Description
Fundamentals
Charts & Quotes
LSYN's News
Suppliers
LSYN's Competitors
Customers & Markets
Economic Indicators
LSYN's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com